APPLICATION
ANDA091322
TYPE
ANDA
ORIGINAL APPROVAL
2011-07-22
LATEST ACTION
2025-09-10
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
MEFENAMIC ACIDPrescription
MEFENAMIC ACID 250MG · CAPSULE · ORAL
Approval history
2025-09-10Manufacturing (CMC) · Supplement 5 · unknownAP
2011-07-22OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.